ADC Therapeutics S.A. (ADCT) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -29.71M | -31.12M | -29.63M | -24.09M | -56.33M | -21.85M | -25.04M | -32.84M | -44.09M | -31.63M | -36.67M | -34.99M |
| Operating CF Margin % | -142.49% | -134.98% | -180.37% | -127.86% | -244.58% | -129.23% | -135.63% | -188.66% | -244.25% | -188.4% | -253.04% | -181.44% |
| Operating CF Growth % | 47.26% | -42.43% | -18.32% | 26.66% | -27.76% | 30.92% | 31.71% | 6.13% | -186.48% | 39.28% | -1770.75% | 34% |
| Net Income | -32.97M | -6.41M | -40.97M | -56.65M | -38.6M | -30.73M | -43.97M | -36.54M | -46.61M | -85.03M | -46.73M | -48.92M |
| Depreciation & Amortization | 114K | 113K | 122K | 1.49M | 801K | 236K | 802K | 838K | 843K | 1.54M | 885K | 812K |
| Stock-Based Compensation | 2.44M | 6.13M | 2M | 2.06M | 2.42M | 2.78M | 2.81M | 1.99M | 158K | 2.22M | 2.08M | 1.12M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -578K | -5.1M |
| Other Non-Cash Items | 5.71M | -19.09M | 8.82M | 7.44M | 8.56M | -488K | 6.78M | 5.69M | 11.43M | 49.41M | 8.13M | 12.09M |
| Working Capital Changes | -5M | -11.87M | 392K | 21.57M | -29.52M | 6.35M | 8.54M | -4.82M | -9.92M | 231K | -463K | 5.02M |
| Change in Receivables | -1.93M | -6.4M | 3.27M | 5.58M | -11.45M | 3.71M | -1.26M | 319K | 2M | -4M | 2.7M | 188K |
| Change in Inventory | 16K | -868.24K | -516K | -706K | -306K | -2.8M | -880K | 518K | -568K | 167K | -3.48M | -2.05M |
| Change in Payables | -3.87M | 1.09M | -1.29M | 0 | -2.46M | 0 | 4.87M | -4.84M | -1.25M | 0 | -2.71M | 2.98M |
| Cash from Investing | -32K | 687.91K | -2.19K | 0 | -264K | -90K | -216K | -30K | -531K | -327K | -661K | -1.21M |
| Capital Expenditures | -32K | -11.57K | -2.19K | 0 | -264K | -90K | -216K | -30K | -531K | -327K | -661K | -1.21M |
| CapEx % of Revenue | 0.15% | 0.05% | 0.01% | - | 1.15% | 0.53% | 1.17% | 0.17% | 2.94% | 1.95% | 4.56% | 6.29% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 699.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -583K | 58.21M | -198K | 93.78M | 271K | -1.12M | -879K | 98.7M | 356K | -1K | 349K | 73.1M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -409K | -261K |
| Equity Issued (Net) | 185K | 59.52M | -479K | -250K | 0 | -1.16M | -1.23M | 0 | 0 | -1K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -20K | 0 | 0 | -250K | 0 | -1.16M | 0 | 0 | 0 | -1K | 0 | 0 |
| Other Financing | -768K | -1.31M | 281K | 94.03M | 271K | 43K | 346K | 98.7M | 356K | 0 | 758K | 73.36M |
| Net Change in Cash | -30.33M | 26.6M | -29.82M | 69.86M | -56.17M | -23.41M | -25.85M | 65.83M | -44.31M | -31.81M | -37.1M | 36.96M |
| Free Cash Flow | -29.74M | -31.13M | -29.63M | -24.09M | -56.6M | -21.94M | -25.26M | -32.88M | -44.63M | -31.96M | -37.33M | -36.2M |
| FCF Margin % | -142.64% | -135.03% | -180.37% | -127.86% | -245.73% | -129.76% | -136.8% | -188.83% | -247.19% | -190.35% | -257.6% | -187.73% |
| FCF Growth % | 47.45% | -41.89% | -17.3% | 26.73% | -26.83% | 31.35% | 32.34% | 9.19% | -171.98% | 38.79% | -2023.44% | 32.74% |
| FCF per Share | -0.19 | -0.21 | -0.22 | -0.21 | -0.53 | -0.21 | -0.24 | -0.34 | -0.54 | -0.39 | -0.45 | -0.44 |
| FCF Conversion (FCF/Net Income) | 0.90x | 4.86x | 0.72x | 0.43x | 1.46x | 0.71x | 0.57x | 0.90x | 0.95x | 0.37x | 0.77x | 0.72x |
| Interest Paid | 0 | 0 | 3.66M | 3.62M | 2.05M | 3.76M | 4.07M | 3.49M | 4.38M | 3.96M | 3.91M | 4.73M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |